Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer

NCT07257458 is registered in ClinicalTrials.gov with Beijing Haidian Hospital as lead sponsor.

NCT NCT07257458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07257458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
Lead sponsor
Beijing Haidian Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 2, 2025
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc)